Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients

Hepatology

Volumn 26, Issue 2, 1997, Pages 432-436

  Cotler, Scott J ^a   Gretch, David R ^a   Bronner, Mary P ^a   Tateyama, Hisashi ^a   Emond, Mary J ^a   Rosaa, Corazon Dela ^a   Perkins, James D ^a   Carithers Jr , Robert L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENT VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS GENOME; VIRUS HEPATITIS;

FLAVIVIRIDAE; GENOTYPE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER TRANSPLANTATION; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030750251     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260225     Document Type: Article

References (34)

1. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter HJ, Koonin E, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-508.
2. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996;334:1536-1537.
3. Simons JN, Leary TP, Dawson GJ. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-569.
4. Bowden DS, Moaven LD, Locarnini SA. New hepatitis viruses: are there enough letters in the alphabet? Med J Aust 1996;164:87-89.
5. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;23:1485-1490.
6. Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, Kim JP, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741-746.
7. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih WK, Kim JP. The incidence of transfusion associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747-754.
8. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown etiology. Lancet 1995;346:1131-1132.
9. Hiramatsu N, Dash S, Sullivan D, Fiel MI, Atillasoy E, Thung SN, Miller CM, et al. Detection of hepatitis G virus (HGV) sequences in liver tissues of patients with fulminant hepatic failure [Abstract]. Gastroenterology 1996;110:A1212.
10. Jeffers LJ, Piatak M, Bernstein DE, Reddy KR, Lifson JD, Yun A, Coelho-Little E, et al. Hepatitis G virus infection in patients with acute and chronic liver disease of unknown etiology [Abstract]. HEPATOLOGY 1995;22:182A.
11. Pessoa MG, Terrault NA, Ferrell L, Kim JP, Kolberg J, Detmer J, Collins M, et al. Detection and quantitation of hepatitis G virus (HGV) in patients with cryptogenic liver disease undergoing liver transplantation [Abstract]. Gastroenterology 1996;110:A1294.
12. Oelsner DH, Caldwell SH, Kim JP, Yun A. Hepatitis G virus prevalence in a cryptogenic cirrhotic population [Abstract]. Gastroenterology 1996; 110:A1282.
13. DiBisceglie AM, Bacon BR, Neuschwnader-Tetri BA, Yun A, Kim JP. Role of hepatitis G virus in cryptogenic liver disease [Abstract]. Gastroenterology 1996;110:A1181.
14. Terrault NA, Piatak M, Kim JP, Kolberg J, Collins M, Detmer J, Yun A, et al. New method for hepatitis G virus (HGV) RNA quantitation in liver transplant (OLT) recipients with HBV/HGV coinfection [Abstract]. Gastroenterology 1996;110:A1344.
15. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, Lake JR, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996;111: 1569-1575.
16. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Coombs KM, Fennessy S, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
17. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C virus infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
18. Gretch DR, Bacci CE, Corey L, Dela Rosa C, Lesniewski RR, Kowdley K, Gown A, et al. Persistent hepatitis C infection after liver transplantation: clinical and virological features. HEPATOLOGY 1995;22:l-9.
19. Gane EJ, Naoumov NV, Qian K, Mondelli MU, Maertens G, Portmann EC, Lau JYN, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-177.
20. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underbill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
21. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
22. Villa E, Grottola A, Buttafoco P, Merighi A, Ferretti I, Trande P, Zoboli P, et al. Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients. Clin Transplant 1995;9:160-164.
23. Gretch D, Wile M, Gaur L, Lesniewski R, Nelson K, Strong M, Johnson R, et al. Donor-recipient match at the HLA-DQB locus is associated with recrudescence of chronic hepatitis following liver transplantation for end stage hepatitis C [Abstract]. HEPATOLOGY 1993;18:108A.
24. Gretch DR, Polyak S, Wilson J, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996; 70:7622-7631.
25. Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992;30:2145-2149.
26. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.; Gen Virol 1992;73:673-679.
27. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995;76:1197-1204.
28. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish T, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
29. Hadziyannis S, Wages J, Kim JP, Karayiannis P, Hess G, Piatak M, Lifson J, et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products [Abstract]. J Hepatol 1995;23:78.
30. Chokshi S, Tzampouras N, Gane E, Smith HM, Naoumov NV, Williams R. The impact of hepatitis GBV-C / HGV agent in patients transplanted for HCV-cirrhosis [Abstract]. HEPATOLOGY 1996;24:419A.
31. Poutous A, Vargas H, Laskus T, Wang L, Radkowski M, Lee R, Demetris J, et al. Hepatitis G virus infection in HCV-positive liver transplant recipients [Abstract]. HEPATOLOGY 1996;24:420A.
32. Rosen HR, Martin P, Shackleton CR, Farmer DA, Holt C, Busuttil RW. OKT3 use associated with diminished graft and patient survival in patients transplanted for chronic hepatitis C [Abstract]. HEPATOLOGY 1995;22:132A.
33. Sheiner PA, Schwanz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. HEPATOLOGY 1995;21:30-34.
34. O'Grady JG, Sutherland S, Harvey F, Calne RY, Alexander GJM, Donaldson PT, Portmann B, et al. Cytomegalovirus infection and donor/ recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988: 2:302-305.